Eliminate Hepatitis C/EC Partnership Evaluation Protocol
NCT04061551 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2021-08-24
Summary
The Eliminate Hepatitis C (EC) Partnership project is a multi-site, multi-year project aiming to enhance and extend hepatitis C virus (HCV) care and treatment among people who inject drugs (PWID) through nurse-led models of care in the community and the prison system. The project will implement and evaluate a health service intervention to enhance HCV response by improving health promotion, offering training and education to service providers, streamlining clinical pathways, utilising data systems and surveillance and implementing the results of ongoing research and evaluation.
Health services data will be used to assess the impact of the EC nurse-led support, to enhance the clinical pathway and increase HCV testing, linkage to care and treatment uptake in community and prison settings. This will include provider and client interviews and a sentinel surveillance system (ACCESS) that will track and monitor impact indicators including HCV testing, linkage to care and treatment uptake at the service and population level.
Overall, evaluation data will be used to monitor the uptake of HCV treatment in PWID, monitor the effectiveness of community- and prison-based treatment program and assess the cost and feasibility of treating \>1160 PWID in community-/prison-based program and assess changes in HCV prevalence in Victoria and modelling the impact of treating PWID to inform HCV elimination models in Australia and globally.
Conditions
- Hepatitis C
- Chronic Hepatitis c
- Hepatitis C, Chronic
Interventions
- OTHER
-
EC clinic support - whole of practice interventions delivery through nurse-led model
The primary interventions will be delivered through a team of nurses, an evaluation team and practice support team that will be working with each of the services to improved Hepatitis C service delivery. The EC project team will predominantly be involved in working with providers and staff at EC sites to implement key interventions that have been collated into a Primary Care Practice Toolkit, which cover three domains; patient support, provider support and practice Support. The toolkit is designed to be an educational and implementation resource that the nursing team will support services to deliver. * Patient support to reduce the impact of hepatitis C and other blood borne viruses * Provider support to reduce the impact of hepatitis C and other blood borne viruses * Practice support to reduce the impact of hepatitis C and other blood borne viruses
Sponsors & Collaborators
-
Burnet Institute
collaborator OTHER -
The Alfred
collaborator OTHER -
St Vincent's Hospital Melbourne
collaborator OTHER -
HepatitisVictoria
collaborator UNKNOWN -
Harm Reduction Australia
collaborator UNKNOWN -
Victoria State Government
collaborator UNKNOWN - collaborator INDUSTRY
-
National Health and Medical Research Council, Australia
collaborator OTHER -
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
lead OTHER
Principal Investigators
-
Margaret E Hellard, MD PhD · Burnet Institute and Alfred Health
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Australia
Study Locations
More Related Trials
-
Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults
NCT04513899 ·Status: COMPLETED ·Phase: NA
-
Reaching mEthadone Users Attending Community pHarmacies With HCV
NCT03935906 ·Status: COMPLETED ·Phase: NA
-
Increasing HCV Linkage to Care Among People Who Inject Drugs
NCT04741750 ·Status: COMPLETED ·Phase: NA
-
Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV
NCT00247884 ·Status: COMPLETED
-
Hepatitis C Pharmacy-based Strategy for Injectors
NCT04698629 ·Status: COMPLETED
-
HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention
NCT03242655 ·Status: COMPLETED ·Phase: NA
-
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
NCT03413696 ·Status: COMPLETED
-
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
NCT01474811 ·Status: COMPLETED
-
Re-link HCV in Substance-Use Telemedicine Program
NCT06349902 ·Status: RECRUITING
-
Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination
NCT05369507 ·Status: COMPLETED ·Phase: NA
-
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
NCT02609893 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
NCT03235154 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis C Treatment in Idaho County Jails
NCT06533319 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pharmacist-led Hepatitis C Management
NCT04322981 ·Status: UNKNOWN ·Phase: PHASE4
-
National Prisons Hepatitis Education Project: Research Evaluation
NCT05942937 ·Status: RECRUITING ·Phase: NA
-
Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs
NCT02755402 ·Status: COMPLETED ·Phase: NA
-
The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach
NCT02363517 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158 ·Status: COMPLETED ·Phase: NA
-
Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV
NCT03356405 ·Status: COMPLETED
-
A Video-Based HCV Curriculum for Active Injection Drug Users
NCT00241943 ·Status: COMPLETED ·Phase: NA
-
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers
NCT04366973 ·Status: COMPLETED
-
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031 ·Status: COMPLETED ·Phase: PHASE4
-
HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment
NCT03524794 ·Status: UNKNOWN
-
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
NCT03364725 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
NCT00194480 ·Status: COMPLETED ·Phase: PHASE4